Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2016 | Transforming the care of patients with precision medicine

Bruce Johnson • 3 Jun 2016
ASCO 2016
General

Bruce Johnson, MD of the Dana-Farber Cancer Institute, Boston, MA and recently elected president of the American Society of Clinical Oncology (ASCO), discusses one of his goals of bringing precision medicine from the academic centers to community practices. As part of this, physicians will need to be provided with the right tools that will allow them to transform the care patients receive around the world.
Recorded at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting, in Chicago, IL.

More from Bruce Johnson

The rising cost of drugs and how to address it
1:34
The rising cost of drugs and how to address it
Bruce Johnson • 3 Jun 2016
The challenges Prof. Bruce Johnson will be faced with as the president of ASCO
0:59
The challenges Prof. Bruce Johnson will be faced with as the president of ASCO
Bruce Johnson • 3 Jun 2016
Challenges associated with developing treatments for solid and rare tumors
1:12
Challenges associated with developing treatments for solid and rare tumors
Bruce Johnson • 3 Jun 2016

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals